Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Beluga Health vs boostAGErx

Beluga Health
Graded #430

Lower grade

vs+10.299999999999997
boostAGErx
Graded #201

Higher grade

The verdict

boostAGErx takes it — 66.1/100 to 55.8/100.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth service selling compounded GLP-1 weight management alongside peptide therapy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +29
45
74
Dose & formulationboostAGErx +24
40
64
Clinical oversightBeluga Health +2
76
74
Labs & monitoringBeluga Health +10
62
52
FulfillmentboostAGErx +21
64
85
Contract termsBeluga Health +30
55
25
Beluga Health · left barboostAGErx · right bar

The numbers

MetricBeluga HealthboostAGErx
WeighScore55.8/10066.1/100
GradeCC
Scorecard rank#430#201
SemaglutideNot disclosed$95/mo (billed every 28 days, compounded)
TirzepatideNot disclosed$145/mo (billed every 28 days, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Beluga Health

Graded #430 · C

Strengths

  • Supports GLP-1 care with compounded semaglutide and tirzepatide
  • Board-certified providers and a 50-state medical infrastructure
  • LegitScript certified with SOC 2 and ISO 27001 security
  • Pharmacies follow FDA/USP standards with third-party batch testing
  • Powers many DTC brands as a turnkey telehealth backbone

Where it loses points

  • White-label B2B group, not a direct consumer-facing service
  • Offers compounded, not FDA-approved branded, GLP-1s
  • No public consumer pricing for the GLP-1 offering
  • Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
  • Care quality varies by the consumer brand using the platform
boostAGErx

Graded #201 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
  • The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
  • Prices are rendered entirely in JavaScript; the page's HTML body is empty, so nothing is readable without running the bundle
  • Shipped compounded medication is non-refundable
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard